Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Page 1
Minimally invasive versus open multivisceral resection for rectal cancer clinically invading adjacent organs: a propensity score-matched analysis.
Abe S, Nozawa H, Sasaki K, Murono K, Emoto S, Yokoyama Y, Matsuzaki H, Nagai Y, Shinagawa T, Sonoda H, Ishihara S. Abe S, et al. Among authors: sasaki k. Surg Endosc. 2024 Apr 24. doi: 10.1007/s00464-024-10844-5. Online ahead of print. Surg Endosc. 2024. PMID: 38658387
The 3-year cancer-specific survival rate, relapse-free survival rate, and cumulative incidence of local recurrence were 75.7, 35.9, and 13.9%, respectively, in the MIS group and 84.5, 45.4, and 27.1%, respectively, in the open group, which were not significantly different (p = 0. …
The 3-year cancer-specific survival rate, relapse-free survival rate, and cumulative incidence of local recurrence were 75.7, 35.9, and 13.9 …
LightGBM outperforms other machine learning techniques in predicting graft failure after liver transplantation: Creation of a predictive model through large-scale analysis.
Yanagawa R, Iwadoh K, Akabane M, Imaoka Y, Bozhilov KK, Melcher ML, Sasaki K. Yanagawa R, et al. Among authors: sasaki k. Clin Transplant. 2024 Apr;38(4):e15316. doi: 10.1111/ctr.15316. Clin Transplant. 2024. PMID: 38607291
Several features like donor age and recipient diabetes history were important in two out of three models. CONCLUSIONS: LightGBM enhances short-term graft survival predictions post-LTx. However, due to changing medical practices and selection criteria, continuous model eval …
Several features like donor age and recipient diabetes history were important in two out of three models. CONCLUSIONS: LightGBM enhances sho …
Long-term results of orbicularis oris muscle reconstruction in primary cleft lip repair using the "basket-weave method".
Sasaki M, Togashi S, Aihara Y, Sasaki K, Shibuya Y, Oshima J, Sekido M. Sasaki M, et al. Among authors: sasaki k. Nagoya J Med Sci. 2024 Feb;86(1):64-71. doi: 10.18999/nagjms.86.1.64. Nagoya J Med Sci. 2024. PMID: 38505716 Free PMC article.
The basket-weave method is an orbicularis oris muscle reconstruction method used in primary unilateral cleft lip repair. We compared the long-term results of the basket-weave method with those of a conventional method. ...The philtrum ridge shape could be reconstructed by …
The basket-weave method is an orbicularis oris muscle reconstruction method used in primary unilateral cleft lip repair. We compared the lon …
Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma.
Sugimoto T, Iwagami Y, Kobayashi S, Yamanaka C, Sasaki K, Yamada D, Tomimaru Y, Asaoka T, Noda T, Takahashi H, Shimizu J, Doki Y, Eguchi H. Sugimoto T, et al. Among authors: sasaki k. Ann Surg Oncol. 2024 Mar 19. doi: 10.1245/s10434-024-15118-x. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38502294
Finally, patients undergoing pancreatic resection for PDAC were divided into two groups based on their serum irisin level, and the long-term outcomes were evaluated. RESULTS: The CM enhanced gemcitabine sensitivity by inducing apoptosis and decreasing cell migration by inh …
Finally, patients undergoing pancreatic resection for PDAC were divided into two groups based on their serum irisin level, and the long-t …
Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer.
Yoshida Y, Toriyabe S, Imai H, Sasaki K, Kasahara Y, Ouchi K, Saijo K, Onodera K, Ishioka C. Yoshida Y, et al. Among authors: sasaki k. Intern Med. 2024 Mar 4. doi: 10.2169/internalmedicine.2931-23. Online ahead of print. Intern Med. 2024. PMID: 38432967 Free article.
We herein report a rare case of TTP that developed after long-term treatment with an ICI (nivolumab) for gastric tube cancer....
We herein report a rare case of TTP that developed after long-term treatment with an ICI (nivolumab) for gastric tube cancer....
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Khouri IF, Alzahrani K, Kantarjian H, Milton DR, Gulbis AM, Sasaki K, Jain N, Short NJ, Kadia T, Daher M, Rafei H, Im JS, Marin D, Olson AL, Popat U, Qazilbash M, Ramdial J, Rondon G, Srour S, Kebriaei P, Shpall E, Champlin R, Jabbour EJ. Khouri IF, et al. Among authors: sasaki k. Am J Hematol. 2024 May;99(5):836-843. doi: 10.1002/ajh.27254. Epub 2024 Feb 23. Am J Hematol. 2024. PMID: 38400519 Clinical Trial.
Here we report on the first prospective study evaluating the safety and long-term survival when an escalating dose of inotuzumab ozogamicin (INO) (0.6, 1.2, or 1.8 mg/m(2) on day 13) was added to one alkylator-containing conditioning regimen in patients with relapsed CD22 …
Here we report on the first prospective study evaluating the safety and long-term survival when an escalating dose of inotuzumab ozog …
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.
Mitani K, Lee JW, Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Murotani K, Shimizu M, Matsuda A, Ozawa K, Nakao S. Mitani K, et al. Among authors: sasaki k. Blood Adv. 2024 Mar 26;8(6):1415-1419. doi: 10.1182/bloodadvances.2023010959. Blood Adv. 2024. PMID: 38134300 Free PMC article. Clinical Trial. No abstract available.
The impact of colonic allograft inclusion on intestinal transplantation outcomes: Results from UNOS/OPTN database analysis.
Matsushima H, Sasaki K, Nair A, Tajima T, Soyama A, Eguchi S, Hashimoto K, Fujiki M. Matsushima H, et al. Among authors: sasaki k. Clin Transplant. 2024 Jan;38(1):e15213. doi: 10.1111/ctr.15213. Epub 2023 Dec 8. Clin Transplant. 2024. PMID: 38064299
Furthermore, conditional graft survival was analyzed to determine long-term outcomes of ICTx. RESULTS: Of 2612 recipients, 506 (19.4%) received ICTx. ...CONCLUSIONS: In the recent transplant era, colonic inclusion is no longer associated with a heightened risk of 6-month A …
Furthermore, conditional graft survival was analyzed to determine long-term outcomes of ICTx. RESULTS: Of 2612 recipients, 506 (19.4% …
Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases.
Paro A, Hyer JM, Avery BS, Tsilimigras DI, Bagante F, Guglielmi A, Ruzzenente A, Alexandrescu S, Poultsides G, Sasaki K, Aucejo F, Pawlik TM. Paro A, et al. Among authors: sasaki k. Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):692-703. doi: 10.21037/hbsn-22-36. Epub 2022 Jun 20. Hepatobiliary Surg Nutr. 2023. PMID: 37886182 Free PMC article.
The odds of "winning" were particularly pronounced relative to short-term outcomes (i.e., 90-day mortality and severity of postoperative complications) (WR: 4.06, 95% CI: 2.33-7.78). ...
The odds of "winning" were particularly pronounced relative to short-term outcomes (i.e., 90-day mortality and severity of postoperat …
331 results